Cleveland Clinic, Cleveland, Ohio, USA.
J Card Fail. 2011 Nov;17(11):893-8. doi: 10.1016/j.cardfail.2011.07.005.
Acute decreases in intrathoracic impedance monitored by implanted devices have been shown to precede heart failure exacerbations, although there is still debate regarding its clinical utility in predicting and preventing future events. However, the usefulness of such information to direct patient encounter and enhance patient recall of relevant preceding clinical events at the point of care has not been carefully examined.
In this multicenter study, we interviewed 326 patients with heart failure who received an implanted device with intrathoracic impedance-monitoring capabilities both before and after device information was reviewed. We compared the self-reported clinically relevant events (including heart failure hospitalizations, signs and symptoms of worsening heart failure, changes in diuretic therapy, or other fluid-related events) obtained before and after device interrogation, and then examined the relationship between such events with impedance trends documented by the devices. Over 333 ± 96 days of device monitoring, 215 of 326 patients experienced 590 intrathoracic impedance fluid index threshold-crossing events at the nominal threshold value (60 Ω-d). Review of device-derived information led to the discovery of 221 (37%) previously unreported clinically relevant events in 138 subjects. This included 60 subjects not previously identified as having had clinically relevant events (or 35% of the 171 subjects who did not report events).
Our data demonstrated that reviewing device-derived intrathoracic impedance trends at the time of clinical encounter may help uncover self-reporting of potential clinically relevant events.
植入设备监测到的胸腔内阻抗急性下降已被证明先于心力衰竭恶化,尽管其在预测和预防未来事件中的临床应用仍存在争议。然而,在医疗保健点指导患者就诊并增强患者对相关既往临床事件的记忆方面,这种信息的有用性尚未得到仔细检查。
在这项多中心研究中,我们采访了 326 名接受植入设备治疗的心力衰竭患者,这些患者在接受设备检查前后都具备胸腔内阻抗监测功能。我们比较了在设备检查前后自我报告的临床相关事件(包括心力衰竭住院、心力衰竭恶化的迹象和症状、利尿剂治疗的变化或其他与液体相关的事件),然后检查了这些事件与设备记录的阻抗趋势之间的关系。在 333 ± 96 天的设备监测期间,326 名患者中有 215 名患者在标称阈值(60 Ω-d)下发生了 590 次胸腔内阻抗流体指数阈值穿越事件。对设备数据的回顾发现了 138 名患者中的 221 例(37%)以前未报告的临床相关事件。这包括 60 名以前未被识别为有临床相关事件的患者(或在未报告事件的 171 名患者中占 35%)。
我们的数据表明,在临床就诊时回顾设备产生的胸腔内阻抗趋势可能有助于发现自我报告的潜在临床相关事件。